News

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...
Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.
Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...
Novo Nordisk AS and a group of insurers will pay $32 million to end litigation over its $1.8 billion acquisition of ...
Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...
The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Novo Nordisk's U.S.-listed shares fell close to 6% Monday after the drugmaker revealed the latest results for a new ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...